‘Azilect,’ Parkinson’s disease treatment, lands in Big 5 hospitals
A treatment, which was newly launched in 10 years in the Parkinson’s disease treatment market, has been safely settled in the ‘Big 5’ hospitals.
According to the healthcare industry on the 15th, ‘Azilect(generic name: rasagiline, Lundbeck Korea), a new Parkinson’s disease treatment, was landed a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
